Congressional Trader
Live

IVW congressional trades

7 matched disclosures

Track congressional trades for IVW
Tracked disclosures
7
Lawmakers
1
Buy / sell
1 / 6
Avg post-trade move
+45.5%
Latest filing 2026-05-11

IVW congressional trades snapshot

This page summarizes public STOCK Act disclosures involving IVW. It is useful for seeing which lawmakers reported IVW transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

May 11, 2026

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the IVW congressional trade page shows

Congressional Trader tracks 7 public STOCK Act disclosures for IVWacross 1 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent IVW filing shown here was filed on May 11, 2026 by John Boozman as a partial sale. Related lawmakers include John Boozman.

Top lawmakers for IVW

Pro performance summary

Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.

Compare Pro plans
John BoozmanR-ARSenate
No committee data
Filed May 11, 2026
Delay 418 days
View filing
IVWNotable
iShares S&P 500 Growth ETF
Partial sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
John BoozmanR-ARSenate
No committee data
Filed Jan 13, 2026
Delay 13 days
View filing
iShares S&P 500 Growth ETF
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
John BoozmanR-ARSenate
No committee data
Filed Apr 20, 2025
Delay 32 days
View filing
IVWNotable
iShares S&P 500 Growth ETF
Partial sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
John BoozmanR-ARSenate
No committee data
Filed Mar 6, 2025
Delay 8 days
View filing
iShares S&P 500 Growth ETF
Partial sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
John BoozmanR-ARSenate
No committee data
Filed Mar 6, 2025
Delay 20 days
View filing
IVWNotable
iShares S&P 500 Growth ETF
Partial sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
John BoozmanR-ARSenate
No committee data
Filed Feb 8, 2025
Delay 11 days
View filing
IVWNotable
iShares S&P 500 Growth ETF
Partial sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
John BoozmanR-ARSenate
No committee data
Filed Jun 5, 2024
Delay 5 days
View filing
iShares S&P 500 Growth ETF
Partial sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade

FAQ

Which lawmakers traded IVW?

Recent IVW disclosures include John Boozman.

What is the buy/sell mix for IVW?

The visible sample currently shows 1 purchases and 6 sales or partial sales.

Should I trade based on IVW disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.